Balloon Catheter

This channel includes news and new technology innovations for angioplasty balloon catheters (PTA). These are used in arteries with atherosclerotic lesions to compress the plaque expand the artery lumen to reopen occluded or heavily stenosed atherosclerotic lesions. Balloons are often used in combination with a stent to prop the treated vessel segment open. In addition to plain old balloon angioplasty (POBA), this section includes news about drug-coated balloon (DCB), valvuloplasty balloons and specialty cutting balloon.

Balloon catheters, cath lab, peripheral artery disease (PAD), Lithoplasty

Shockwave's Lithoplasty System, an innovative treatment for patients with peripheral artery disease (PAD).

News | January 13, 2015
January 13, 2015 — Shockwave Medical announced CE Mark regulatory approval for the company’s Lithoplasty balloon...
News | January 09, 2015
January 9, 2015 — Covidien announced it has received CE Mark approval for its Stellarex drug-coated angioplasty balloon...
Medtronic, In.Pact, Admiral drug-coated balloon, DCB, drug-eluting balloon
Technology | January 05, 2015
January 5, 2015 — The U.S. Food and Drug Administration (FDA) has cleared Medtronic’s In.Pact Admiral drug-coated...
Balloon catheters, clinical trial/study, drug-eluting balloon, IN.PACT Admiral

Image courtesy of Medtronic, Inc.

News | December 29, 2014
December 29, 2014 — The results of a study published online and in Circulation indicate that a medical device from...
balloon catheters, clinical trial/study, medtronic, IN.PACT Admiral drug-coated

Photo courtesy of Medtronic

News | December 26, 2014
December 26, 2014 — The results of a landmark study published this month in Circulation indicate that a device from...

Image courtesy of Cardionovum

News | December 19, 2014
December 19, 2014 — Cardionovum GmbH announced that it has initiated a 150-patient clinical study of its novel...
Balloon catheter, interventional radiology, FDA clearance, kidney disease

Image courtesy of Covidien

Technology | December 04, 2014
December 4, 2014 — Covidien announced that it received U.S. Food and Drug Administration 510(k) clearance for its...
News | November 14, 2014
Nov. 14, 2014 — Covidien releases 12-month results of the DEFINITIVE AR study, the first randomized study designed to...
News | November 13, 2014
Nov. 13, 2014 — Optimizing the treatment of coronary artery disease with a new foundation for future stent innovations...
TriReme, PTA Chocolate Balloon, valvuloplasty, heart valve repair
News | November 12, 2014
Nov. 12, 2014 — Catalist-listed QT Vascular Ltd. has acquired a novel technology platform called Java, and all...
Shockwave, lithoplasty, lithotripsy

Before and after images of a heavily calcified peripheral artery disease (PAD) lesion treated with Shockwave's lithoplasty technology.

Feature | November 11, 2014
Nov. 11, 2014 — Shockwave Medical announced positive clinical results from Disrupt PAD trial, a single-arm multicenter...
Feature | November 10, 2014
Nov. 10, 2014 — For the treatment of peripheral artery disease in leg arteries above the knee, the IN.PACT Admiral drug...
News | November 04, 2014
November 4, 2014 — Shockwave Medical announced that the company will present clinical results from DISRUPT PAD, a...
News | October 31, 2014
October 31, 2014 — Metro Health (Michigan) cardiovascular specialist Jihad Mustapha, M.D., is one of the first...
News | October 29, 2014
October 29, 2014 — Restenosis, the recurrence of narrowing of the arteries after stenting, is a common risk of this...